ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,518Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 1383

$887K Total Retail Price of All Prescriptions

Rank: 82 out of 1383

563 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 14,935 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 821 613 1 3
FUROSEMIDE 758 640 2 7
METOPROLOL TARTRATE 649 589 3 9
LEVOTHYROXINE SODIUM 636 548 4 4
HYDROCODONE-ACETAMINOPHEN 578 483 S3 5 1
OMEPRAZOLE 496 338 6 5
POTASSIUM CHLORIDE 477 445 7 12
CITALOPRAM HBR 442 354 8 15
SIMVASTATIN 410 354 9 2
AMLODIPINE BESYLATE 381 313 10 6
SERTRALINE HCL 356 306 11 21
METFORMIN HCL 301 235 12 8
LANTUS SOLOSTAR 298 269 13 112
HYDROCHLOROTHIAZIDE 295 210 14 10
ATENOLOL 292 224 15 16
GABAPENTIN 270 185 16 11
LOSARTAN POTASSIUM 244 191 17 23
FAMOTIDINE 225 208 18 61
PRAVASTATIN SODIUM 210 173 19 14
WARFARIN SODIUM 207 174 20 13
NAMENDA 199 189 21 49
TAMSULOSIN HCL 185 140 22 30
LOVASTATIN 183 141 23 22
ZOLPIDEM TARTRATE 179 130 24 17
CARVEDILOL 176 136 25 24
DONEPEZIL HCL 169 163 26 35
CLOPIDOGREL 167 141 27 28
ALLOPURINOL 162 121 28 33
CYMBALTA 154 111 29 53
ISOSORBIDE MONONITRATE ER 150 138 30 66
PAROXETINE HCL 146 111 31 55
BUSPIRONE HCL 144 135 32 109
HUMALOG 141 127 33 176
RISPERIDONE 140 110 34 71
TRAZODONE HCL 136 83 35 36
CRESTOR 136 81 35 34
GLIMEPIRIDE 135 101 37 31
NEXIUM 130 76 38 26
ATORVASTATIN CALCIUM 124 100 39 18
ALBUTEROL SULFATE 116 93 40 124
METOPROLOL SUCCINATE 111 73 41 29
PLAVIX 108 93 42 43
PREDNISONE 106 102 43 40
SPIRIVA 103 60 44 45
DIGOXIN 97 97 45 59
VENLAFAXINE HCL ER 96 56 46 102
MIRTAZAPINE 95 86 47 51
LEVOFLOXACIN 93 86 48 88
CARBIDOPA-LEVODOPA 90 78 49 108
AZITHROMYCIN 86 66 50 41
IPRATROPIUM-ALBUTEROL 85 84 51 138
ALENDRONATE SODIUM 82 73 52 37
LACTULOSE 79 66 53 128
TERAZOSIN HCL 74 70 54 111
DOXAZOSIN MESYLATE 74 66 54 120
SPIRONOLACTONE 72 41 56 67
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 66 57 89
DIOVAN 70 67 58 58
MELOXICAM 68 34 59 20
EXELON 67 67 60 117
LEVETIRACETAM 67 44 60 134
DIVALPROEX SODIUM 67 67 60 78
KLOR-CON 10 67 55 60 74
DILTIAZEM 24HR CD 67 66 60 95
ENALAPRIL MALEATE 64 52 65 75
GEMFIBROZIL 62 57 66 90
PROAIR HFA 62 43 66 42
POLYETHYLENE GLYCOL 3350 61 39 68 64
NOVOLOG FLEXPEN 59 48 69 229
GLYBURIDE 57 55 R 70 46
ADVAIR DISKUS 56 47 71 63
LYRICA 56 33 71 72
AMOXICILLIN 55 38 73 119
OLANZAPINE 54 49 74 164
BENAZEPRIL HCL 53 52 75 38
TRAMADOL HCL 53 21 75 25
NITROGLYCERIN PATCH 53 53 75 177
SINGULAIR 52 38 78 82
DOXYCYCLINE HYCLATE 52 48 78 94
NITROSTAT 51 42 80 186
VENLAFAXINE HCL 51 42 80 192
ROPINIROLE HCL 51 27 80 79
IBUPROFEN 51 29 80 91
CIPROFLOXACIN HCL 50 46 84 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.